Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03259841|
Recruitment Status : Recruiting
First Posted : August 24, 2017
Last Update Posted : April 24, 2018
|Condition or disease||Intervention/treatment|
|Gastroparesis||Other: Ultrasound assessment of gastric contet|
|Study Type :||Observational|
|Estimated Enrollment :||240 participants|
|Official Title:||Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy|
|Actual Study Start Date :||October 31, 2017|
|Estimated Primary Completion Date :||September 14, 2018|
|Estimated Study Completion Date :||October 14, 2019|
Fasted patients for cholecyctectomy
The fasted patients for cholecyctectomy except exclusion criteria are included
Other: Ultrasound assessment of gastric contet
Ultrasound assessment of gastric content is performed in fasted patient undergoing cholecystectomy.
- Incidence of full stomach [ Time Frame: Before the induction of anesthesia ]The incidence of full stomach is assessed by using ultrasonography.
- Cross sectional area of the stomach [ Time Frame: Before the induction of anesthesia ]The cross sectional area of the stomach is assessed by using ultrasonography in the supine and right lateral positions.
- Volume of stomach [ Time Frame: Before the induction of anesthesia ]The volume of stomach is assessed using the following formula; volume of stomach (mL) = 27.0 + 14.6 x cross-sectional area (right lateral position) - 1.28 x age.
- Type of gastric contents [ Time Frame: Before the induction of anesthesia ]The type of gastric contents is assessed using ultrasonography.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03259841
|Contact: Jin-Young Hwang, M.D., Ph.D.||email@example.com|
|Korea, Republic of|
|Seoul Metropolitan Government Seoul National University Boramae Medical Center||Recruiting|
|Seoul, Korea, Republic of, 156-707|
|Contact: Jin-Young Hwang, M.D. +82-2-870-2518 firstname.lastname@example.org|
|Principal Investigator:||Jin-Young Hwang, M.D., Ph.D.||SMG-SNU Boramae Medical Center|